Clinical Trial Update: Seprafilm® Adhesion Barrier and Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial update on the Seprafilm adhesion barrier used during cesarean delivery; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Adhesions
• Obstetric Delivery Complications

Drugs mentioned

• Seprafilm Adhesion Barrier (Hyaluronic acid / carboxymethylcellulose)

Snippet

Sponsor: Winthrop University Hospital | Conditions: Adhesions, Cesarean Section | Phase 4 | Status: COMPLETED | Results posted: 2016-04-22